Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.34 |
| ▸ | NAAA | Q02083 | 1/20 | 0.32 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5224647 | 0.77 | CYP2C19 (0.40) | CHRM3CYP2C19EPHX1CYP19A1 | |
| SCHEMBL16234619 | 0.69 | CYP3A4 (0.42) | CHRM3MAPT | |
| SCHEMBL16086282 | 0.66 | CYP2C19 (0.48) | CHRM3CYP2C19EPHX1NAAACYP19A1 | |
| SCHEMBL27660738 | 0.65 | CYP2C19 (0.49) | CHRM3CYP2C19EPHX1NAAACYP19A1 | |
| SCHEMBL9485096 | 0.64 | CYP2C19 (0.52) | CHRM3CYP2C19EPHX1NAAACYP19A1 | |
| SCHEMBL16086274 | 0.64 | CYP2C19 (0.47) | CHRM3CYP2C19EPHX1NAAACYP19A1 | |
| SCHEMBL28778803 | 0.64 | CYP2C19 (0.52) | CHRM3CYP2C19EPHX1NAAACYP19A1 | |
| SCHEMBL5493739 | 0.64 | CYP2C19 (0.52) | CHRM3CYP2C19EPHX1NAAACYP19A1 | |
| SCHEMBL28983033 | 0.64 | CYP1A2 (0.44) | CYP1A2MAPT | |
| SCHEMBL27873180 | 0.64 | CYP1A2 (0.34) | CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050272132-A1 | Production of polyketides and other natural products | BIOTICA TECHNOLOGY LIMITED (GB) | 2005-12-08 | — | — | US | disclosed |